Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Cue Health Inc.

Cue is a healthcare technology company that develops and manufactures diagnostic devices for at-home and point-of-care use.

Cue is a healthcare technology company that puts consumers in control of their health information and places diagnostic information at the center of care. Cue's mission is to empower people to live their healthiest lives through personalized, proactive, and informed healthcare.

Cue enables people to manage their health through real-time, actionable, and connected health information, offering individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, anytime, in a device that fits in the palm of the hand.

Cue's first-of-its-kind COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription and physician supervision. Cue was founded in 2010 and is headquartered in San Diego. For more information, please visit www.cuehealth.com.

Fraudulent Recruitment Alert: Please be aware of fraudulent job opportunities and offers not affiliated with Cue Health. For a list of current opportunities, please visit: https://cuehealth.wd1.myworkdayjobs.com/cuehealth

Biomedical Advanced Research and Development Authority (BARDA)

U.S. Department of Defense

U.S. Department of Health & Human Services

Perceptive Advisors

MSD Capital

Johnson & Johnson Innovation – JJDC

Koch Strategic Platforms

Decheng Capital

ACME Capital

CAVU Consumer Partners

Johnson & Johnson

Dentsu Ventures

Madrone Capital Partners

Foresite Capital

Cue Health

Congratulations to Brittany Williams Grieb, Pat Kinshofer, and Aaron Halda for being recognized as our Cue Spotlight winners for November!

Every month, People Managers from across our organization have the opportunity to nominate members of their team for Cue Spotlight, which is our company-wide recognition program for employees who truly exemplify our mission, vision, and values.

Brittany Williams was nominated for building boldly.
Pat Kinshofer was nominated for winning together.
Aaron Halda was nominated for excelling every day.

We appreciate your hard work and dedication to Cue! #WeAreCue

This week members of our Vets & Allies at Cue Employee Resource Group, open to all employees, volunteered at the Veterans Village of San Diego. 

Veterans Village of San Diego (VVSD) has served all Veterans since 1981 and is dedicated to “Leave No One Behind.” Each year VVSD helps thousands of our most vulnerable Veterans to reclaim their lives through programs that offer transitional and permanent housing, mental health counseling, substance use treatment, and employment and training services.

Employees could use their Volunteer Time Off (VTO) for the ERGs first event at VVSD. We're thankful for everyone's help, time, and dedication to help Veterans in need. #WeAreCue #LifeAtCue

California Life Sciences has announced the winners of its 20th annual Pantheon Awards. We are proud to share we won the 2023 Pantheon Award in the Medtech, Digital, & Diagnostic category. 

This year's 20th Annual Award ceremony took place in San Francisco, recognizing and celebrating California’s leading scientific innovators.

“Congratulations to the winners of the 20th Annual Pantheon Awards,” said Mike Guerra, CLS president & CEO. “They are shining examples of dedication to scientific advancement and innovation, and they inspire us to keep pushing boundaries in pursuit of new solutions for patients around the world.”

Read the official California Life Sciences (CLS) press release: http://spr.ly/6049uqTZV #Pantheon2023

Every month, People Managers from across our organization have the opportunity to nominate members of their team for Cue Spotlight. 

Cue Spotlight is our company-wide recognition program for employees who truly exemplify our mission, vision, and values. 

Congratulations to our Cue Spotlight winners from September:
Sydney M. was nominated for winning together.
Joshua Clemente was nominated for winning together.
David Ornelas was nominated for winning together.

Congratulations to our Cue Spotlight winners from October:
Victor Hernandez was nominated for being accountable.
Devin Flanagan was nominated for excelling every day.

We appreciate your hard work and dedication to Cue! #WeAreCue

The risks associated with COVID-19 infection are higher for immunocompromised individuals than the general public. 

If you, or someone you know, is immunocompromised or age 65+, please consider joining the ImmunoCARE study, which provides free molecular COVID-19 tests, telemedicine, and rapid home delivery of medication, if prescribed.

ImmunoCARE is an innovative research project to study whether repeated at-home tests, on-demand telemedicine, and quick delivery of medication for those who test positive for COVID-19 can reduce COVID-19 severity in immunocompromised people.

We are excited to partner with Scripps Research Digital Trials Center on this joint research project and hope you will consider joining us in helping to advance research on COVID-19 outcomes for immunocompromised individuals. 

Click here to see if you or someone you know is eligible to participate: http://spr.ly/6049Z0CPS

If you're experiencing symptoms, you can now gain peace of mind without making a trip to the doctor's office. 

Our molecular COVID-19 test allows you to test from home and receive results on your mobile phone in about 20 minutes. And with options for virtual care and prescription medication delivery, you can stay confident knowing fast, timely access to treatment is available if you ever need it.

Discover how we've made it easy to get the care you need: http://spr.ly/6040ZpMA4

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue	6.63M -	22.95M 246.41%	618.11M 2,592.92%	483.48M 21.78%	70.94M 85.33%
cost of revenue		14.95M -	276.54M 1,749.66%	329.97M 19.32%	127.09M 61.48%
gross profit	6.63M -	8.00M 20.77%	341.56M 4,168.50%	153.50M 55.06%	-56.16M 136.58%
selling and marketing expenses	88K -	714K 711.36%	28.73M 3,923.67%	88.58M 208.33%	32.58M 63.22%
general and administrative expenses	5.90M -	23.94M 305.69%	79.79M 233.34%	97.10M 21.70%	57.35M 40.93%
selling general and administrative expenses	5.99M -	24.65M 311.66%	108.52M 340.23%	185.68M 71.11%	89.94M 51.56%
research and development expenses	21.41M -	28.48M 33.04%	42.83M 50.39%	171.45M 300.32%	150.62M 12.15%
other expenses	309K -	47K 84.79%	-59.29M 126,244.68%	2.49M 104.20%	162K 93.50%
cost and expenses	27.39M -	68.08M 148.53%	427.89M 528.52%	687.11M 60.58%	367.65M 46.49%
operating expenses	27.39M -	53.13M 93.95%	151.35M 184.87%	357.13M 135.97%	240.56M 32.64%
interest expense	152K -	984K 547.37%	9.81M 896.85%	645K 93.42%	1.16M 79.69%
ebitda	-16.80M -	-38.80M 130.87%	130.93M 437.48%	-201.14M 253.62%	-240.44M 19.54%
operating income	-20.77M -	-45.13M 117.30%	98.42M 318.10%	-203.63M 306.90%	-296.71M 45.71%
depreciation and amortization	3.96M -	6.33M 59.74%	32.51M 413.65%	2.49M 92.33%	56.28M 2,157.44%
total other income expenses net	161K -	-2.23M 1,482.61%	20.75M 1,032.39%	-172K 100.83%	-71.96M 41,735.47%
income before tax	-20.61M -	-47.35M 129.80%	119.18M 351.68%	-203.80M 271.01%	-368.67M 80.89%
income tax expense	461K -	1.03M 123.64%	32.76M 3,077.40%	-9.75M 129.76%	4.79M 149.17%
net income	-21.07M -	-48.38M 129.66%	86.42M 278.61%	-194.06M 324.56%	-373.46M 92.45%
weighted average shs out	128.04M -	128.04M 0%	52.82M 58.75%	148.02M 180.27%	152.88M 3.28%
weighted average shs out dil	135.39M -	135.39M 0%	59.64M 55.95%	148.02M 148.22%	152.88M 3.28%
eps	-0.16 -	-0.38 137.50%	0.63 265.79%	-1.31 307.94%	-2.44 86.26%
epsdiluted	-0.16 -	-0.36 125.00%	0.59 263.89%	-1.31 322.03%	-2.44 86.26%

COM:CUEHEALTH

Cue

Last Close

0.06

05/06 20:00

Market Cap

6.90M

Beta: -

Volume Today

50.91M

Avg: -

Preview